In patients with inflammatory arthritis, excessive growth of synovium is part of ... a rare condition in which very aggressive growth of the synovium occurs hemophilia There are two basic forms of ...

Joint protection strategies help prevent the chronic arthritis that historically plagued hemophilia patients. Proper body mechanics, assistive devices when needed, maintaining healthy weight ...

World Hemophilia Day is observed on April 17. It raises awareness about bleeding disorders. Hemophilia is a genetic condition causing prolonged bleeding. Early diagnosis and treatment are crucial.

Doctors say if it is not diagnosed early, the constant bleeding into joints, bones, and muscles can lead to painful arthritis and permanent joint deformities. It can even result in death. Those with ...

Hemophilia is a rare bleeding disorder where the blood doesn’t clot the way it should, making even minor injuries potentially serious. According to the Centers for Disease Control and Prevention ...

The US Food and Drug Administration (FDA) has approved fitusiran (Qfitlia, Sanofi) for bleeding prophylaxis in patients aged 12 years or older with hemophilia A and B with or without factor VIII ...

To evaluate the usefulness of this concentrate in patients with hemophilia B ... from the National Institute of Arthritis and Metabolic Diseases (patient studies were carried out in part at ...

Lentiviral vector (LV)–based gene therapy using CD34+ hematopoietic stem cells (HSCs) demonstrated stable factor VIII expression in severe hemophilia A patients, with higher vector copy numbers ...

Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. The New York pharma is ending global development and commercialization of ...

for all bleeds was reduced by approximately 90% from lead-in as compared to year four "Hemophilia B can cause spontaneous bleeds into the joints, resulting in extreme pain and progressive, ...